Appropriate leucine-rich α-2 glycoprotein cut-off value for Japanese patients with ulcerative colitis

Table 1 Baseline characteristics of the 30 patients

Parameter	Patients (n = 30)
Age, year, median (IQR)	37 (28-47)
Male/Females, n/n	21/9
Disease duration, year, median (IQR)	1 (0-1)
Actual disease extent, n (%)
Proctitis	3 (10)
Left-sided colitis	7 (23.3)
Total colitis	20 (66.7)
Segmental colitis	0
Laboratory data
LRG, μg/mL, median (IQR)	11.9 (9.8-20.1)
CRP, mg/dL, median (IQR)	0.10 (0.10-0.33)
Medication, n (%)
5-aminosalicylic acid	30 (100)
Immunomodulators	3 (10)
Anti-TNF	2 (6.7)
Ustekinumab	1 (3.3)
Tofacitinib	3 (10)

IQR: Interquartile range; LRG: Leucine-rich α-2 glycoprotein; CRP: C-reactive protein; TNF: Tumor necrosis factor.